MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Genetic testing for EBS3 pinpoints BP230 mutations, enabling accurate diagnosis, personalized care, family planning insights, and contributes to future therapy research.
Discover how genetic testing aids in diagnosing and managing Epidermolysis Bullosa Simplex 4, offering early detection, personalized care, and insights for family planning.
Unlock the potential of genetic testing in diagnosing FAME4, a subtype of familial adult myoclonic epilepsy, for accurate diagnosis, family planning, and treatment.
Delve into Familial Adult Myoclonic Epilepsy 5, a hereditary neurological disorder. Explore how genetic testing aids in diagnosis, treatment, and family planning.
Explore Estrogen Resistance Syndrome and discover how genetic testing enables early diagnosis, personalized treatment, and informed family planning for ERS.
Explore how genetic testing deciphers Facial Dysmorphism-Immunodeficiency-Livedo-Short Stature Syndrome, aiding in diagnosis, management, and family planning insights.
Explore how genetic testing uncovers mutations in familial episodic pain syndrome, aids in personalized treatments, and guides informed family planning decisions.
Explore the role of genetic testing in diagnosing Fanconi anemia complementation group Q, linked to RFWD3 mutations, for early intervention and personalized treatment.